Compare ENSC & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENSC | FAT |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 6.6M |
| IPO Year | N/A | 2017 |
| Metric | ENSC | FAT |
|---|---|---|
| Price | $0.90 | $0.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 443.4K | 413.8K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,487,973.00 | ★ $574,143,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.51 | N/A |
| 52 Week Low | $0.86 | $0.31 |
| 52 Week High | $9.57 | $6.17 |
| Indicator | ENSC | FAT |
|---|---|---|
| Relative Strength Index (RSI) | 22.39 | 19.14 |
| Support Level | $0.86 | $0.31 |
| Resistance Level | $1.24 | $0.42 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 7.72 | 3.64 |
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.